Amicus Therapeutics, Inc.

VANGUARD GROUP INC FOLD

Report date

12/31/2025

Quarter

2025 Q4

Filed

1/29/2026

Shares

29,702,696

Value ($000)

422,966

Weight

0.0%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	1/29/2026	422,966	0.0%	29,702,696	12/31/2025
2025 Q3	11/7/2025	232,728	0.0%	29,534,029	9/30/2025
2025 Q2	8/11/2025	168,505	0.0%	29,407,588	6/30/2025
2025 Q1	5/9/2025	237,053	0.0%	29,050,621	3/31/2025
2024 Q4	2/11/2025	275,619	0.0%	29,258,963	12/31/2024
2024 Q3	11/13/2024	307,593	0.0%	28,800,820	9/30/2024
2024 Q2	8/13/2024	283,599	0.0%	28,588,606	6/30/2024
2024 Q1	5/10/2024	332,247	0.0%	28,204,309	3/31/2024
2023 Q4	3/11/2024	404,308	0.0%	28,492,486	12/31/2023
2023 Q3	12/18/2023	329,924	0.0%	27,131,873	9/30/2023
2023 Q2	8/14/2023	339,427	0.0%	27,024,417	6/30/2023
2023 Q1	7/14/2023	297,899	0.0%	26,861,945	3/31/2023
2022 Q4	2/10/2023	324,034	0.0%	26,538,371	12/31/2022
2022 Q3	11/14/2022	270,095	0.0%	25,871,062	9/30/2022
2022 Q2	8/12/2022	276,363	0.0%	25,732,089	6/30/2022
2022 Q1	5/13/2022	242,973	0.0%	25,657,170	3/31/2022
2021 Q4	2/14/2022	296,202	0.0%	25,645,184	12/31/2021
2021 Q3	11/12/2021	233,866	0.0%	24,488,601	9/30/2021
2021 Q2	8/13/2021	238,392	0.0%	24,729,400	6/30/2021
2021 Q1	5/14/2021	240,945	0.0%	24,387,053	3/31/2021
2020 Q4	2/12/2021	550,591	0.0%	23,845,433	12/31/2020
2020 Q3	11/16/2020	327,409	0.0%	23,187,567	9/30/2020
2020 Q2	8/14/2020	363,620	0.0%	24,112,736	6/30/2020
2020 Q1	5/15/2020	222,856	0.0%	24,118,586	3/31/2020
2019 Q4	2/14/2020	231,414	0.0%	23,759,160	12/31/2019
2014 Q2	8/11/2014	4,546	0.0%	1,361,170	6/30/2014
2014 Q1	5/13/2014	2,550	0.0%	1,231,741	3/31/2014
2013 Q4	2/12/2014	2,798	0.0%	1,190,481	12/31/2013